Trial Site Networks: Create Positive Change Through A Shift in Perspective
COVID-19 represents a stress test of sorts for our global healthcare system that will hopefully lead to positive changes over [...]
Patient Intelligence and Insights Reports Available from Self Care Catalysts
Patients negotiate a shifting landscape of goals and aspirations. They have to navigate unmet needs, barriers to care, influencers and [...]
Submit Your Abstracts for Virtual ISPOR 2021
Abstract Submissions Are Open for Virtual ISPOR 2021; May 17 – 20: "HEOR: Evolving for Tomorrow's Challenges" Submit under the [...]
Adaptive Trial Designs in Early Oncology
Our understanding of the genetic and molecular mechanisms that lead to cancer have improved greatly over the past decade thanks [...]
Bart Heeg on New Trends in HEOR
In this two-part blog series, Bart Heeg, Vice President HEOR and Founder at Ingress Health (A Cytel company) discusses trends [...]
Draft Scoping Document for the Assessment of Alzheimer’s Disease Posted by ICER
Yesterday the Institute for Clinical and Economic Review (ICER) posted a Draft Scoping Document detailing the planned review of the comparative clinical effectiveness [...]
FDA Approved NDA for KOSELUGO™ (selumetinib)
Recently the FDA approved AstraZeneca’s KOSELUGO™ (selumetinib) for treatment of pediatric patients two years of age and older with neurofibromatosis [...]
Pfizer Seeks Judgment Favoring Proposed Patient-assistance Programs
If Pfizer wins their lawsuit against the U.S. government, Medicare stands to spend much, much more on some drugs. Pfizer [...]
Thomas Wilke Weighs In On Health Economics and Real-World Evidence Studies
In this interview, Thomas Wilke, Principal Scientist at Ingress-Health (a Cytel company), discusses his background and experience in HEOR to [...]
Lessons Learned from COVID-19 Health Preference Research
The COVID-19 pandemic caused a major shift in the lives of many HEOR researchers, especially those conducting health preference research. [...]
Building a More Consumer-Centric Future in the Era of COVID
The urgent need to scale healthcare innovation has been unmasked by the COVID-19 pandemic, making consumerism an essential tenet of [...]
Beyond Real-World Data and COVID-19
Join Casey Ross and other industry leaders as they discuss applications of real-world data in the battle against Covid-19. In [...]
[Podcast] The MM+M Podcast: FDA’s Bakul Patel
Bakul Patel has been leading regulatory and scientific efforts related to digital health devices at the FDA since 2010. Tune [...]
What Does the Rise of Real-World Evidence Mean For Pharma?
The COVID-19 pandemic has highlighted the urgent need for real-world evidence to inform decision making. This month’s issue of ISPOR [...]
Unlocking the Promise of Real-World Evidence
At present, researchers have an abundance of real-world data. Although these data have been primarily used for safety surveillance, they [...]
Updates From the Real-World Evidence Transparency Initiative
The ISPOR Real-World Evidence (RWE) Transparency Initiative moves forward towards the Society’s goals while underscoring the need for transparency in [...]
[ebook] Version 4.1 of the AMCP Format: Product Dossiers
On December 23, 2019, the Academy of Managed Care Pharmacy (AMCP) released Version 4.1 of the AMCP Format for Formulary [...]
Accountable Care Organizations Generate $1.19 billion in Savings to Medicare
CMS recently announced that accountable care organizations generated $1.19 billion in total net savings to Medicare in 2019, proving the [...]
Dascena’s COViage Receives Emergency Use Authorization from FDA
The FDA issued an Emergency Use Authorization to a clinical decision support (CDS) tool that predicts when hospitalized COVID patients [...]
High Standards Needed to Inspire Trust in Digital Health Companies
Digital health companies are making big promises about affordability, access, prevention, early detection and intervention. Proponents claim that these companies [...]
[Webinar] Driving Value and Sustainable Health Care Economics Through Consumer Engagement
Tune in to this on-demand webinar to hear industry leaders David Wichmann, CEO, UnitedHeath Group, Laura Kaiser, President & CEO, [...]
ICER Releases Final Report and Policy Recommendations for Ulcerative Colitis Treatments
The Institute for Clinical and Economic Review (ICER) recently released a Final Evidence Report and Report-at-a-Glance evaluating comparative clinical effectiveness and value of the [...]
ICER Publishes Evidence Report on Therapies for Hemophilia A
Today the Institute for Clinical and Economic Review (ICER) released a report concluding that compared to common current dosing levels [...]
How is it Possible For an X-ray Price to Be Unknowable? Convenience!
On Thursday a panel of three judges heard oral arguments in a case that could usher in a great many [...]
Has Value-based Care Truly Moved the Needle?
Humana recently published a report stating that Medicare Advantage members covered by value-based care (VBC) arrangements have better outcomes and lower [...]